CA Patent

CA2497977A1 — Use of cytokine synthesis inhibitors for the treatment of dry eye disorders

Assigned to Alcon Inc · Expires 2004-04-01 · 22y expired

What this patent protects

Inhibitors of cytokine synthesis in nonimmune, resident ocular surface cells are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.

USPTO Abstract

Inhibitors of cytokine synthesis in nonimmune, resident ocular surface cells are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.

Drugs covered by this patent

Patent Metadata

Patent number
CA2497977A1
Jurisdiction
CA
Classification
—
Expires
2004-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Alcon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.